Bronchoscopic study on aetiology of chronic cough in HIV-infected adults with negative sputum smears for Mycobacterium tuberculosis at Kenyatta National Hospital, Nairobi

East African Medical Journal

Volumn 83, Issue 6, 2006, Pages 295-305

  Siika, A M ^a   Chakaya, J M ^b   Revathi, G ^c   Mohamed, S S ^d   Bhatt, K M ^e  

^a MOI UNIVERSITY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c AGA KHAN UNIVERSITY   (Kenya)

^d KENYATTA NATIONAL HOSPITAL   (Kenya)

^e UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748496460     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v83i6.9436     Document Type: Article

References (31)

1. UNAIDS. AIDS epidemic update: December 2005.
2. WHO/UN AIDS, Summary country profiles for HIV / AIDS Treatment scale-up, June 2005. www.who.int/3by5.
3. The Kenya Demographic and Health Survey 2003. Central Bureau of Statistics, Ministry of Planning and National Development.
4. National AIDS Control Council of Kenya. The Kenya National HIV/AIDS strategic plan 2000-2005.
5. WHO World Health Report - 2000, Appendix 5 pp182
6. th ed. McGraw-Hill. 2001; Vol 2: pp1880-1884.
7. Mills J. Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect. Dis. 1986; 8: 1001-1011
8. Rana F.S., Hawken M.P., Mwachari P., et al. Autopsy study of HIV-1 positive and HIV-1 negative adult medical patients in Nairobi, Kenya. J. Acquired Immune Defic. Syndr. 2000; 24: 23-29.
9. Harries A.D. Tuberculosis and HIV-1 infection in developing countries. Lancet 1990; 335: 387-390.
10. McLeod D.T., Neill P., Gwanzura L., et al. Pneumocystis carinii pneumonia in patients with AIDS in Central Africa. Resp. Med. 1990; 84: 225-228.
11. Abouya Y.L., Beaumel A., Lucas S., et al. Pneumocystis carinii pneumonia: an uncommon cause of death in Africans. Amer. Rev. Respir. Dis. 1992; 145: 617-620.
12. Batungwanayo J., Taelman H., Lucas J., et al. Pulmonary disease associated with HIV in Kigali, Rwanda: A fibreoptic bronchoscopic study of 111 cases of undetermined etiology. Amer. J. Respir. Crit. Care Med. 1994; 149: 1591-1596.
13. Van Soy R.E. Bacterial sputum cultures: a clinician's viewpoint. Mayo Clin. Proc. 1977; 52: 39-41.
14. Murray P.R. and Washington J.A. II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin. Proc. 1975; 50: 339-344.
15. Murray J.F. and Mills F. Pulmonary complications of HIV infection. Amer. Rev. Respir. Dis. 1990; 141: 1356-1372.
16. Klech H. and Pohl W. Technical recommendations and guidelines for broncho-alveolar lavage: Report of the European Society of Pneumonology Task Force on BAL. Euro. Respir. J. 1989; 2: 561-585.
17. Raoof S., Rosen M.J., Khan F.A., et al. Role of bronchoscopy in AIDS. Clin. Chest Med. 1999; 20: 63-76.
18. Serwadda D., Goodgame R., Lucas S. and Kocjan G. Absence of Pneumocystis carinii in Ugandan AIDS patients. (Letter) AIDS. 1989; 3: 47-48.
19. Elvin K.M., Lumbwe O.M., Luo N.P., et al. Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia. Trans. R. Soc. Trop. Med. Hyg. 1989; 83: 553-555.
20. Carme B., Mboussa J., Andzin M., et al. Pneumocystis carinii is rare in AIDS in Central Africa. Trans. R. Soc. Trop. Med. Hyg. 1991; 85: 80.
21. Malin A.S., Gwanzura L.K., Klein S., et al. Pneumocystis carinii in Zimbabwe. Lancet. 1995; 346: 1258-1261.
22. Mahomed A.G., Murray J., Klempman S., et al. PCP in HIV Infected patients from South Africa. East Afr. Med. J. 1999; 76: 80-84.
23. Chakaya J.M., Bu C., Ng'ang'a L., et al. Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya. East Afr. Med. J. 2003; 80: 30-35.
24. 1997 IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: disease specific recommendations. Clin. Infect. Dis. 1997; 25: S313-S335.
25. Anglaret X., Chene G., Attia A., et al. Early chemoprophylaxis with trimethoprim suphamethoxazole for HIV-1 infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet. 1999; 353: 1463-1468.
26. Wiktor S.Z., Sassan-Moroko M., Grant A.D., et al. Efficacy of trimethoprim suphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised trial. Lancet. 1999; 353: 1469-1475.
27. Badri M., Ehrlich R., Wood R. and Maartens G. Initiating co-trimoxazole prophylaxis in HIV infected patients in Africa; an evaluation of the provisional WHO/UNAIDS recommendations. AIDS. 2001; 15: 1143-1148.
28. Mermin J., Lule J., Ekwaru J.P., et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet. 2004; 364: 1428-1434.
29. Lee B.L., Padula A.M., Kimbrough R.C., et al. Infectious complications with respiratory pathogens despite Ciprofloxacin therapy. N. Engl. J. Med. 1991; 325: 520-521.
30. Scott J.A., Hall A.J., Hannington A., et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin. Infect. Dis. 1998; 27: 1442-1450.
31. Kell C.M., Jordens J.Z., Daniels M., et al. Molecular epidemiology of penicillin-resistant pneumococci isolated in Nairobi Kenya. Infect. Immun. 1993; 61: 4382-4391.